USFDA inspects Alkem Laboratories’ Bioequivalence facility at Taloja

15 Jul 2017 Evaluate

The US Food and Drug Administration (USFDA) has conducted an inspection at Alkem Laboratories’ Bioequivalence facility located at Taloja in state of Maharashtra from July 10, 2017 to July 14, 2017. At the end of the inspection, no Form 483 was issued.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories Share Price

4597.05 -51.70 (-1.11%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.